Musculoskeletal pain is a worldwide disorder that transcends demographics and age. These disorders not only impact older individuals but also affect people across the age spectrum (
1). Musculoskeletal disorders are the second leading cause of disability worldwide, with persistent pain largely attributed to musculoskeletal conditions (
1,
2). During their lifetime, 60% to 80% of the population experiences low back pain (LBP), a form of musculoskeletal pain. Of these individuals with acute LBP, more than 30% may develop chronic LBP (
3). Low back pain is a major health disorder with significant social and economic costs (
4). It affects a large proportion of the population, and its toll on patients, society, and families makes improving treatment for this common, yet benign disorder a principal aim (
5,
6). Low-level light therapy (LLLT) is an alternative approach to pharmacological management for chronic LBP (
7). Despite its extensive use, the effectiveness of LLLT is controversial (
8). Traditional methods include physical therapy, medication, education, and back exercises, but these methods do not help in all cases. A large number of patients seek alternative methods, such as LLLT (
9,
10). The Multiwave Locked System (MLS), a type of LLLT laser, has been shown to reduce inflammation and enhance biostimulation, influencing tendons, enhancing the functionality of ligaments by reducing thickness, reducing the severity of patient pain, and increasing the function of myoblasts to enhance muscle tissue recovery (
11). Additionally, MLS Laser has shown clinical improvement in vascular conditions, including Raynaud’s phenomenon (
12). The MLS is used by various medical practitioners in Europe and the United States to decrease inflammation and pain in different cases (
7). Many patients have experienced success with MLS treatments, including in orthopedic cases.